Global health service company Cigna Corporation has released the results of its 2019 Cigna 360 Well-Being Surv...Read more
A study by Onco.com, the world’s first online cancer care platform, has come up with startling findings ...Read more
Chugai Pharmaceutical has announced that it has obtained regulatory approval for the humanized anti-human IL-6...Read more
Researchers at Okayama University report in the journal Sensors and Actuators B: Chemical that terah...Read more
Medtronic plc, the global leader in medical technology, has announced the launch of the Medtronic MedTech Inno...Read more
Veeda Clinical Research Pvt. Ltd., a leading independent CRO has announced that its clinical (Shivalik, Ahmeda...Read more
3Ps augmenting drug discovery in APAC
Beyond meeting the needs of global pharma in simply providing access to patient pools and lower operational costs, the Asia-Pacific (APAC) region is also poised to realize the potential of a thriving biotechnology sector that is driving innovation on its own. APAC is gaining the experience and infrastructure needed to support the global biotech industry by performing work and fostering innovation through public private partnership (3Ps) that is moving up the pharmaceutical value chain.